COVID-19 presenting with autoimmune hemolytic anemia in the setting of underlying immune dysregulation

Pediatr Blood Cancer. 2020 Sep;67(9):e28382. doi: 10.1002/pbc.28382. Epub 2020 Jun 3.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, N.I.H., Extramural

MeSH terms

  • Adolescent
  • Adrenal Cortex Hormones / administration & dosage
  • Anemia, Hemolytic, Autoimmune* / blood
  • Anemia, Hemolytic, Autoimmune* / diagnosis
  • Anemia, Hemolytic, Autoimmune* / pathology
  • Anemia, Hemolytic, Autoimmune* / therapy
  • Benzoates / administration & dosage
  • Betacoronavirus / metabolism*
  • COVID-19
  • Coronavirus Infections* / blood
  • Coronavirus Infections* / diagnosis
  • Coronavirus Infections* / pathology
  • Coronavirus Infections* / therapy
  • Erythrocyte Transfusion
  • Humans
  • Hydrazines / administration & dosage
  • Male
  • Mycophenolic Acid / administration & dosage
  • Oxygen / administration & dosage
  • Pandemics*
  • Pneumonia, Viral* / blood
  • Pneumonia, Viral* / diagnosis
  • Pneumonia, Viral* / pathology
  • Pneumonia, Viral* / therapy
  • Pyrazoles / administration & dosage
  • SARS-CoV-2

Substances

  • Adrenal Cortex Hormones
  • Benzoates
  • Hydrazines
  • Pyrazoles
  • Mycophenolic Acid
  • eltrombopag
  • Oxygen